NCT06603753View on ClinicalTrials.gov

Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).

Not yet recruitingOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

July 1, 2026

Conditions

Hyperbilirubinemia, Neonatal

All Listed Sponsors

lead

alaa aboelhassan mohamed aboelhassan

OTHER